首页> 美国卫生研究院文献>Journal of Translational Medicine >Expression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancer
【2h】

Expression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancer

机译:淋巴结转移中上皮到间充质转移相关标志物的表达可作为乳腺癌原发性肿瘤转移潜力的替代物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundBreast cancers are phenotypically and genotypically heterogeneous tumors containing multiple cancer cell populations with various metastatic potential. Aggressive tumor cell subpopulations might more easily be captured in lymph nodes metastases (LNM) than in primary tumors (PT). We evaluated mRNA and protein levels of master EMT regulators: TWIST1, SNAIL and SLUG, protein levels of EMT-related markers: E-cadherin, vimentin, and expression of classical breast cancer receptors: HER2, ER and PgR in PT and corresponding LNM. The results were correlated with clinicopathological data and patients outcomes.
机译:背景乳腺癌是表型和基因型异质性肿瘤,包含多个具有不同转移潜能的癌细胞群。在淋巴结转移(LNM)中比在原发性肿瘤(PT)中更容易捕获侵略性肿瘤细胞亚群。我们评估了主要EMT调节剂的mRNA和蛋白质水平:TWIST1,SNAIL和SLUG,EMT相关标记的蛋白质水平:E-钙粘着蛋白,波形蛋白,以及经典乳腺癌受体HER2,ER和PgR在PT和相应LNM中的表达。结果与临床病理数据和患者预后相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号